MML Investors Services’s NovoCure NVCR Stock Holding History

MML Investors Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$297K	Buy	+19,573	New	+$296K	﹤0.01%	2832
2023 Q1	–	Sell	-3,302	Closed	-$242K	–	2203
2022 Q4	$242K	Buy	3,302 +340	+11%	+$25.6K	﹤0.01%	1914
2022 Q3	$225K	Buy	+2,962	New	+$231K	﹤0.01%	1864
2022 Q2	–	Sell	-4,032	Closed	-$334K	–	2102
2022 Q1	$334K	Sell	4,032 -586	-13%	-$43.2K	﹤0.01%	1656
2021 Q4	$347K	Buy	4,618 +424	+10%	+$42.6K	﹤0.01%	1615
2021 Q3	$487K	Buy	4,194 +542	+15%	+$81.9K	﹤0.01%	1371
2021 Q2	$810K	Buy	3,652 +1,206	+49%	+$235K	0.01%	1092
2021 Q1	$323K	Sell	2,446 -8	-0.3%	-$1.26K	﹤0.01%	1476
2020 Q4	$425K	Buy	+2,454	New	+$336K	﹤0.01%	1244

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

MML Investors Services's NVCR Position: Q2 2026 in Review

MML Investors Services opened a new position in NovoCure (NVCR) in Q2 2026: 19,573 shares worth $297K. The stake represents ﹤0.01% of the portfolio and ranks #2832 among its holdings. This is a return to the name: MML Investors Services previously reported a position in NVCR as recently as Q4 2022.

MML Investors Services first reported a position in NVCR in Q4 2020 and has held it in 9 quarters since. The position peaked at $810K in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

MML Investors Services held 19,573 shares of NovoCure worth $297K as of Q2 2026.
NovoCure was a new MML Investors Services position in Q2 2026.
NovoCure made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2832 holding.
MML Investors Services first reported a position in NovoCure in Q4 2020 and has held it in 9 quarters since.
MML Investors Services's NovoCure position peaked at $810K in Q2 2021.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.